Activation of aerobic metabolism by Amaranth oil improves heart rate variability both in athletes and patients with type 2 diabetes mellitus

Archives of Physiology and Biochemistry

Volumn 118, Issue 2, 2012, Pages 47-57

  Yelisyeyeva, Olha ^a   Semen, Khrystyna ^a   Zarkovic, Neven ^b   Kaminskyy, Danylo ^a   Lutsyk, Olexander ^a   Rybalchenko, Volodymyr ^c  

^a DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^b RUDER BO KOVI INSTITUTE   (Croatia)

^c TARAS SHEVCHENKO NATIONAL UNIVERSITY OF KYIV   (Ukraine)

Author keywords

Aerobic metabolism; Amaranth oil; Athletes; Correlations; Heart rate variability; Hormesis; Metabolic syndrome; Oxidative stress correction; Type 2 diabetes mellitus

Indexed keywords

REACTIVE OXYGEN METABOLITE; VEGETABLE OIL;

ADULT; AEROBIC METABOLISM; AMARANTHUS; ARTICLE; ATHLETE; CHEMISTRY; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIET THERAPY; DRUG EFFECT; FEMALE; HEART RATE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PLANT SEED;

AEROBIOSIS; AMARANTHUS; ATHLETES; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PLANT OILS; REACTIVE OXYGEN SPECIES; SEEDS; YOUNG ADULT;

AMARANTHUS CAUDATUS;

EID: 84860703211     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2012.659259     Document Type: Article

References (70)

1. Angulo P. (2002). Nonalcoholic fatty liver disease. N Engl J Med 346:1221-31.
2. Aubert AE, Seps B, Beckers F. (2003). Heart rate variability in athletes. Sports Med 33:889-919. (Pubitemid 37255452)
3. Belcher JD, Beckman JD, Balla G, Balla J, Vercellotti G. (2010). Heme degradation and vascular injury. Antioxid Redox Signal 12:233-48.
4. Bilyi O, Dudok K, Lukyanez V. (1998). Determination of the hemoglobin content and its ligand forms in blood using the method of absorptive spectroscopy. Lviv: Lviv State University Press (in Ukrainian):24 pp.
5. Bochkov VN, Oskolkova OV, Birukov KG, Levonen A-L, Binder CJ, Stockl J. (2010). Generation and biological activities of oxidized phospholipids. Antioxid Redox Signal 12:1009-59.
6. Bosquet L, Mekari S, Arvisais D, Aubert AE. (2008). Is heart rate a convenient tool to monitor overreaching? A systematic review of the literature. Br J Sports Med 42:709-14.
7. Chang Y-C, Chuang L-M. (2010). The role of oxidative stress in the pathogenesis of type 2 diabetes: from molecular mechanism to clinical implication. Am J Transl Res 2:316-31.
8. Cherkas A, Yelisyeyeva O, Semen K, Zarkovic K, Kaminskyy D, Gasparovic AC, Jaganjac M, Lutsyk A, Waeg G, Zarkovic N. (2009). Persistent accumulation of 4-hydroxynonenal-protein adducts in gastric mucosa after Helicobacter pylori eradication. Coll Antropol 33:815-21.
9. Choi SW, Benzie IF, Ma SW, Strain JJ, Hannigan BM. (2008). Acute hyperglycemia and oxidative stress: Direct cause and effect? Free Rad Biol Med 44:1217-31.
10. Christensen JH, Skou HA, Madsen T, Terring I, Schmidt EB. (2001). Heart rate variability and n-3 polyunsaturated fatty acids in patients with diabetes mellitus. J Int Med 249:545-52. (Pubitemid 32823863)
11. Churruca I, Fernandez-Quintela A, Portillo MP. (2009). Conjugated linoleic acid isomers: Differences in metabolism and biological effects. Biofactors 35:105-11.
12. Cohen G, Riahi Y, Alpert E, Gruzman A, Sasson S. (2007). The roles of hyperglycaemia and oxidative stress in the rise and collapse of the natural protective mechanism against vascular endothelial cell dysfunction in diabetes. Arch Physiol Biochem 113:259-67.
13. Cohen G, Riahi Y, Sasson S. (2011). Lipid peroxidation of polyunsaturated fatty acids in normal and obese adipose tissues. Arch Physiol Biochem 117:131-39.
14. Connes P, Hue O, Hardy-Dessources MD, Boucher JH, Pichot V, Barthelemy JC. (2008). Hemorheology and heart rate variability: is there a relationship? Clin Hemorheol Microcirc 38:257-65. (Pubitemid 351521577)
15. Das UN. (2000). Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how? Prostagland Leukotrien Essent Fatty Acids 63:351-62. (Pubitemid 32096974)
16. Del Rio R, Moya EA, Iturriaga R. (2010). Carotid body and cardiorespiratory alterations in intermittent hypoxia: the oxidative link. Eur Respir J 36:143-50.
17. Dubinina E, Burmistrov S, Khodov D, Porotov I. (1995). Oxidative modification of human blood serum proteins: a method for its estimation. Vopr Med Chimii (in Russian) 41:24-9.
18. Eckardt K, Sell H, Eckel J. (2008). Novel aspects of adipocyteinduced skeletal muscle insulin resistance. Arch Physiol Biochem 114:287-98.
19. Eizirik DL, Cardozo AK, Cnop M. (2008). The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 29:42-61. (Pubitemid 351252746)
20. Ellis EM. (2007). Reactive carbonils and oxidative stress: potential for therapeutic intervention. Pharmacol Therapeutics 115:13-24. (Pubitemid 46990552)
21. Ezenwaka CE, Nwagbara E, Seales D, Okali F, Sell H, Eckel J. (2009). Insulin resistance, leptin and monocyte chemotactic protein-1 levels in diabetic and non-diabetic Afro-Caribbean subjects. Arch Physiol Biochem 115:22-7.
22. Fisher-Wellman K, Bell HK, Bloomer RJ. (2009). Oxidative stress and antioxidant defense mechanisms linked to exercise during cardiopulmonary and metabolic disorders. Oxid Med Cell Longevity 2:43-51.
23. Gamel TH, Mesallam AS, Damir AA, Shekib LA, Linssen JP. (2007). Characterization of Amaranth seed oils. J Food Lipids 14:323-34. (Pubitemid 47293690)
24. Guzy RD, Schumacker PT. (2006). Oxygen sensing by mitochondria at complex III: The paradox of increased ROS during hypoxia. Exp Physiol 91:807-19. (Pubitemid 44266577)
25. Haensel A, Mills PJ, Nelesen RA, Ziegler MG, Dimsdale JE. (2008). The relationship between heart rate variability and inflammatory markers in cardiovascular diseases. Psychoneuroendocrinol 33:1305-12.
26. Henriksen EJ, Diamond-Stanic MK, Marchionne EM. (2011). Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Rad Biol Med 51:993-99.
27. Howorka K, Pumprla J, Haber P, Koller-Strametz J, Mondrzyk J, Schabmann A. (1997). Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy. Cardiovasc Res 34: 206-14. (Pubitemid 27261931)
28. Iellamo F, Legramante JM, Pigozzi F, Spataro A, Norbiato G, Lucini D, Pagani M. (2002). Conversion from vagal to sympathetic predominance with strenuous training in high-performance world class athlete. Circulation 105:2719-24. (Pubitemid 34615141)
29. Jones DP. (2006). Disruption of mitochondrial redox circuitry in oxidative stress. Chem Biol Interact 163:38-53. (Pubitemid 44572221)
30. Kaikkonen P, Hynynen E, Mann T, Rusko H, Nummela A. (2010). Can HRV be used to evaluate training load in constant load exercises? Eur J Appl Physiol 108:435-42.
31. Kaminskyy DV, Yelisyeyeva OP, Chercas AP, Kurkevych AK, Konyk UV, Darmogray RY, Aleksevich YI. (2002). Physical and chemical characteristic of amaranth and peculiarities of its metabolic influence. Medical Chemistry (in Ukrainian) 4:77-85.
32. Kamyshnikov VS (Ed.). (2000). Reference on clinical biochemical laboratory diagnostics (in 2 volumes). Minsk: Belarus. V.1 495 pp.; V.2 494 pp.
33. Kim YM, Pae HO, Park JE, Lee YC, Woo JM, Kim NH, Choi YK, Lee BS, Kim SR, Chung HT. (2011). Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 14:137-167.
34. Korolyuk M, Ivanova L, Mayorova I, Tokarev V. (1998). A method for measuring catalase activity. Lab Delo (in Russian) 1:16-9.
35. Kostyuk V, Potapovich A, Kovaleva Z. (1990). A simple sensitive assay for determination of superoxide dismutase activity based on reaction of quercetin oxidation. Vopr Med Khimii (in Russian) 2:88-91. (Pubitemid 20094361)
36. Kuhn H, Gotze R, Schewe T, Rapoport S. (1981). Quasi-lipoxygenaze activity of haemoglobin a model for lipoxygenases. Eur J Biochem 120:161-68. (Pubitemid 12218970)
37. Lahiri MK, Kannankeril PJ, Goldberger JJ. (2008). Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol 51:1725-33. (Pubitemid 351608496)
38. Mandl J, Meszaros T, Banhegyi G, Hunyady L, Csala M. (2009). Endoplasmic reticulum: nutrient sensor in physiology and pathology. Trends Endocrinol Metab 20:194-201.
39. Mangoni ME, Nargeot J. (2008). Genesis and regulation of the heart automaticity. Physiol Rev 88:919-82.
40. Manoli I, Alesci S, Blackman MR, Su YA, Rennert OM, Chrousos GP. (2007). Mitochondria as key components of the stress response. Trends Endocrinol Metab 18:190-98. (Pubitemid 46970733)
41. Martinmi K, Rusko H.(2008). Time-frequency analysis of heart rate variability during immediate recovery from low and high intensity exercise. Eur J Appl Physiol. 102,353-60. (Pubitemid 350245960)
42. Martirosyan DM, Miroshnichenko LA, Kulakova SN, Pogojeva AV, Zoloedov VI. (2007). Amaranth oil application for coronary heart disease and hypertension. Lipids Health & Disease 6:1-12.
43. Mattson MP. (2008). Dietary factors, hormesis and health. Ageing Res Rev 7:43-8.
44. Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R, Chapple S, Feher J, et al. (2010). Pathological aspects of lipid peroxidation. Free Radic Res 44:1125-71.
45. Negre-Salvayre A, Salvayre R, Aug N, Pamplona R, Portero-Ot M. (2009). Hyperglycemia and glycation in diabetic complications. Antioxid Redox Signal 11:3071-109.
46. Packer L, Cadenas E. (2007). Oxidants and antioxidants revisited. New concepts of oxidative stress. Free Radical Res 41:951-52. (Pubitemid 47343397)
47. Pollack GH, Figueroa X, Zhao Q. (2009). Molecules, water, and radiant energy: New clues for the origin of life. Int J Mol Sci 10:1419-29.
48. Radak Z, Chung HY, Goto S. (2008). Systemic adaptation to oxidative challenge induced by regular exercise. Free Rad Biol Med 44:153-59.
49. Rains JL, Jain SK. (2011). Oxidative stress, insulin signaling, and diabetes. Free Rad Biol Med 50:567-75.
50. Riahi Y, Sin-Malia Y, Cohen G, Alpert E, Gruzman A, Eckel J, Staels B, Guichardant M, Sasson S. (2010). The natural protective mechanism against hyperglycemia in vascular endothelial cells roles of the lipid peroxidation product 4-hydroxydodecadienal and peroxisome proliferator-activated receptor δ. Diabetes 59:808-18.
51. Sarsour EH, Kumar MG, Chaudhuri L, Kalen AL, Goswami PC. (2009). Redox control of the cell cycle in health and disease. Antioxid Redox Signal 11:2985-3011.
52. Sasson S, Eckel J. (2006). Disparate effects of 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid in vascular endothelial and smooth muscle cells and in cardiomyocytes. Arch Physiol Biochem 112:119-29. (Pubitemid 44384780)
53. Semen KO, Yelisyeyeva OP, Kaminskyy DV, Cherkas AP, Zarkovic K, Lutsyk OO, Cipak A, Jaganjac M, Zarkovic N. (2010). Interval hypoxic training in complex treatment of Helicobacter pylori-associated peptic ulcer disease. Acta Biochim Pol 57: 199-208.
54. Sen CK, Khanna S, Roy S. (2007). Tocotrienols in health and disease: the other half of the natural vitamin E family. Mol Aspects Med 28:692-728. (Pubitemid 47625534)
55. Shin DH, Heo HJ, Lee YJ, Kim HK. (2004). Amaranth squalene reduces serum and liver lipid levels in rats fed a cholesterol diet. Br J Biomed Sci 61:11-4. (Pubitemid 38445333)
56. Sirota TV, Yelisyeyeva OP, Khunderyakova NV, Makhotina OA. (2008). Amaranth seed oil: effect of oral administration on energetic functions of rat liver mitochondria activated with adrenaline. Biochem (Moscow) Suppl Series A: Memb Cell Biol 2:40-7. (Pubitemid 351486669)
57. Stuchlik M, Zak S. (2002). Vegetable lipids as components of functional foods. Biomed Papers 146:3-10.
58. Task Force of the ES of Cardiology and the North AmS of Pacing and Electrophysiology. (1996). Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17:354-81.
59. Timirbulatov R, Seleznev E. (1986). Methods for increasing intensity of free radical oxidation of blood lipids containing components and its diagnostic value. Lab Delo (in Russian) 4:209-11.
60. Trayhurn P, Christian A, Drevon CA, Eckel J. (2011). Secreted proteins from adipose tissue and skeletal muscle-adipokines, myokines and adipose/muscle cross-talk. Arch Physiol Biochem 117:47-56.
61. Tymochko M, Yelisyeyeva O, Kobylinska L, Tymochko I. (1998). Metabolic aspects of the oxygen homeostasis formation in the extremal states. Lviv (Ukraine):Missioner, 142 pp.
62. Valko M, Leibfrit D, Moncol J, Cronin MT, Mazur M, Telser J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44-84. (Pubitemid 44566469)
63. Voeikov VL, Del Giudice E. (2009). Water respiration-The basis of the living state. Water 1:52-75.
64. Wang R, Kern JT, Goodfriend TL, Ball DL, Luesch H. (2009). Activation of the antioxidant response element by specific oxidized metabolites of linoleic acid. Prostagland Leukotrien Essent Fatty Acids 81:53-9.
65. Weseler AR, Bast A. (2010). Oxidative stress and vascular function: implications for phramacologic treatment. Curr Hypertens Rep 12:154-61.
66. Widmer CC, Pereira CP, Gehrig P, Vallelian F, Schoedon G, Buehler PW, Schaer DJ. (2010). Hemoglobin can attenuate hydrogen peroxide-induced oxidative stress by acting as an antioxidative peroxidase. Antioxid Redox Signal 12:185-198.
67. Yelisyeyeva O, Cherkas A, Semen K, Kaminskyy D, Lutsyk A. (2008a). Study of aerobic metabolism parameters and heart rate variability and their correlations in elite athletes: a modulatory effect of Amaranth oil. CEMED 3:293-307.
68. Yelisyeyeva O, Cherkas A, Zarkovic K, Semen K, Kaminskyy D, Waeg G, Zarkovic N. (2008b). The distribution of 4-hydroxynonenalmodified proteins in gastric mucosa of duodenal peptic ulcer patients. Free Rad Res 42:205-11. (Pubitemid 351419906)
69. Yelisyeyeva O, Serhiyenko O, Cherkas A, Semen K, Kaminskyy D, Kurkevych A. (2005). Heart rate variability in patients with diabetes mellitus: an attempt of metabolic interpretation. Probl Endocr Pathol (in Ukrainian) 1:95-110.
70. Zarkovic N. (2003). 4-Hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med 24:281-91. (Pubitemid 36945028)